Insmed’s Brensocatib Enters Trial as Possible COVID-19 Treatment
Insmed is sponsoring a clinical trial in the UK of its bronchial drug Brensocatib as a potential COVID-19 treatment.
Source: Drug Industry Daily
Insmed is sponsoring a clinical trial in the UK of its bronchial drug Brensocatib as a potential COVID-19 treatment.
Source: Drug Industry Daily